CREKA peptide

CREKA peptide is a short peptide sequence, belonging to self-assembling peptides (SAPs), which can self-assemble into functional nanostructures, typically nanofibers, under physiological conditions. CREKA peptide can be used to target tumor cells and tumor vasculature, exhibiting antitumor activity[1].

Product Specifications

CAS Number

[847058-45-1]

UNSPSC

12352209

Target

Biochemical Assay Reagents

Type

Peptides

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/creka-peptide.html

Purity

98.07

Smiles

O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](C)C(O)=O)=O)=O)=O)[C@H](CS)N

Molecular Formula

C23H43N9O8S

Molecular Weight

605.71

References & Citations

[1]Zhang N, et al. Recent advances of CREKA peptide-based nanoplatforms in biomedical applications. J Nanobiotechnology. 2023 Mar 3;21 (1) :77.

Shipping Conditions

Blue Ice

Storage Conditions

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

Scientific Category

Peptides

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

C3498-50 50 mg

Enniatin Complex

Ask

View Details

E43S47621 100 µL

Alpha 1 Antitrypsin Recombinant Rabbit mAb

Ask

View Details

GTR15117254 1 Vial

Lentiviral human IER3IP1 shRNA (UAS) - Lentiviral human IER3IP1 shRNA (UAS, iRFP) (25)

Ask

View Details

MBS245037-01 0.125 mg

Mouse Monoclonal [clone OX-21] (IgG1) to Human CFI / Complement Factor I

Ask

View Details

MBS245037-02 5x 0.125 mg

Mouse Monoclonal [clone OX-21] (IgG1) to Human CFI / Complement Factor I

Ask

View Details